| Dec 5, 2025 |
Dec 8, 2025 |
Adverum Biotechnologies, Inc.
|
CEO |
Buy |
97.5
|
+128,699
|
176.75%
|
✗
|
$553.9K |
| May 15, 2025 |
May 16, 2025 |
Adverum Biotechnologies, Inc.
|
CEO |
Sell |
26.3
|
-9,126
|
-9.45%
|
✗
|
$18.3K |
| Mar 15, 2023 |
Mar 17, 2023 |
Adverum Biotechnologies, Inc.
|
CEO |
Sell |
26.3
|
-41,239
|
-5.62%
|
✗
|
$32.2K |
| Sep 19, 2022 |
Sep 21, 2022 |
Adverum Biotechnologies, Inc.
|
CEO |
Sell |
26.3
|
-41,082
|
-5.35%
|
✗
|
$43.9K |
| Apr 20, 2022 |
Apr 22, 2022 |
Adverum Biotechnologies, Inc.
|
CEO |
Buy |
83.8
|
+25,000
|
3.39%
|
✗
|
$27.8K |
| Dec 8, 2021 |
Dec 10, 2021 |
Adverum Biotechnologies, Inc.
|
CEO |
Buy |
83.8
|
+25,000
|
3.51%
|
✗
|
$45.6K |
| Mar 24, 2021 |
Mar 24, 2021 |
Adverum Biotechnologies, Inc.
|
CEO |
Buy |
95.0
|
+10,000
|
61.38%
|
✗
|
$98.8K |
| Jan 15, 2021 |
Jan 19, 2021 |
Adverum Biotechnologies, Inc.
|
CEO |
Buy |
95.0
|
+8,600
|
111.80%
|
✗
|
$99.2K |
| Aug 17, 2020 |
Aug 19, 2020 |
Adverum Biotechnologies, Inc.
|
CEO |
Buy |
95.0
|
+7,692
|
100.00%
|
✗
|
$100K |
| Sep 16, 2019 |
Sep 18, 2019 |
Mirum Pharmaceuticals, Inc.
|
Director |
Buy |
91.3
|
+2,100
|
45.16%
|
✗
|
$19.7K |
| Sep 6, 2019 |
Sep 10, 2019 |
Mirum Pharmaceuticals, Inc.
|
Director |
Buy |
91.3
|
+4,650
|
100.00%
|
✗
|
$49.3K |